Vietnam Approves Merck’s Gardasil For Females Over Age 10
This article was originally published in PharmAsia News
Vietnam's Health Ministry cleared Merck to market its Gardasil vaccine in the country for preventing the human papillomavirus responsible for cervical cancer. In approving the three-shot treatment for females over the age of 10, the ministry also advised importers, distributors and those who administer the vaccine to report on their activities semi-annually. Cervical cancer is detected in Vietnam at the rate of two in 10,000 women and has a mortality rate of more than 50 percent. (Click here for more
You may also be interested in...
US regulators refused to accept the file for one of Y-mAbs's neuroblasoma drugs – omburtamab – in October but have given the green light to a second one, naxitamab.
Fueled by a pipeline of more than 15 biosimilar candidates, Sandoz is aiming to treble the size of its $2bn global biosimilars business by 2030, targeting the US, Europe and Japan. Management spoke at length about the firm’s achievements and prospects during a meeting of parent Novartis’ management.
Rather than hitting the acquisition trial, Biogen has taken the licensing route to expand its psychiatric and neurological disorders pipeline.